BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34772646)

  • 1. Long-term mortality after ST-elevation myocardial infarction in the reperfusion and modern secondary prevention therapy era according to coronary artery disease extent: The FAST-MI registries.
    Brunet T; Bonello L; Chamandi C; Tea V; Nallet O; Lhermusier T; Gallet R; Labèque JN; Albert F; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2021 Oct; 114(10):647-655. PubMed ID: 34772646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: Lessons from CRAC, a French prospective multicentre registry.
    Rangé G; Saint Etienne C; Marcollet P; Chassaing S; Dequenne P; Hakim R; Capsec J; Laure C; Gautier S; Albert F; Godillon L; Stolt P; Motreff P; Grammatico-Guillon L
    Arch Cardiovasc Dis; 2019 Jan; 112(1):3-11. PubMed ID: 30655225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes in myocardial infarction and multivessel disease after a cardiac rehabilitation programme: Partial versus complete revascularization.
    Mori Junco R; Dalmau Gonzalez-Gallarza R; Castro Conde A; González Fernandez O; Álvarez Ortega C; Blázquez Bermejo Z; Furuya-Kanamori L; Moreno Gomez R; López de Sa Arreses E
    Arch Cardiovasc Dis; 2017 Apr; 110(4):234-241. PubMed ID: 28082243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is coronary multivessel disease in acute myocardial infarction patients still associated with worse clinical outcomes at 1-year?
    Puymirat E; Nakache A; Saint Etienne C; Marcollet P; Fichaux O; Decomis MP; Chassaing S; Commeau P; Danchin N; Cayla G; Montalescot G; Benamer H; Koning R; Motreff P; Rangé G
    Clin Cardiol; 2021 Mar; 44(3):429-437. PubMed ID: 33586188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
    de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E; Tea V; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2021 Feb; 114(2):88-95. PubMed ID: 33011156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.
    Ahmad Y; Howard JP; Arnold A; Prasad M; Seligman H; Cook CM; Warisawa T; Shun-Shun M; Ali Z; Parikh MA; Al-Lamee R; Sen S; Francis D; Moses JW; Leon MB; Stone GW; Karmpaliotis D
    J Am Heart Assoc; 2020 Jun; 9(12):e015263. PubMed ID: 32476540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial.
    Calviño-Santos R; Estévez-Loureiro R; Peteiro-Vázquez J; Salgado-Fernández J; Rodríguez-Vilela A; Franco-Gutiérrez R; Bouzas-Mosquera A; Rodríguez-Fernández JÁ; Mesías-Prego A; González-Juanatey C; Aldama-López G; Piñón-Esteban P; Flores-Ríos X; Soler-Martín R; Seoane-Pillado T; Vázquez-González N; Muñiz J; Vázquez-Rodríguez JM
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e007924. PubMed ID: 31554422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.